In re­or­ga­ni­za­tion, Jo­erg Moeller gath­ers all the phar­ma R&D reins at Bay­er as dis­cov­ery chief ex­its

Im­age: An­dreas Busch (left) and Jo­erg Moeller (right). Bay­er

An­dreas Busch, the head of dis­cov­ery at Bay­er, is ex­it­ing the com­pa­ny. And Bay­er is meld­ing its ear­ly re­search and de­vel­op­ment op­er­a­tions un­der one of­fice oc­cu­pied by cur­rent de­vel­op­ment chief Jo­erg Moeller.

There’s no im­me­di­ate word on where Busch is head­ed, but the boom­ing bio­phar­ma scene has trig­gered a wide­spread glob­al mi­gra­tion among phar­ma, biotech and aca­d­e­m­ic groups.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER